Related Experiment Videos
[Case report on a patient with SUNCT-syndrome]
S Neumeier1, T Brinkschmidt, U Jensen
1Tagesklinik für Schmerztherapie, Abteilung für Anästhesiologie und Operative Intensivmedizin, Städtisches Krankenhaus, München-Neuperlach, Munich. Dr-Susanne.Neumeier@extern.lrz-muenchen.de
Schmerz (Berlin, Germany)
|April 16, 2003
Summary
Short-lasting, unilateral neuralgiform headache attacks with conjunctival injection, sweating, and rhinorrhoea (SUNCT) syndrome was effectively treated with gabapentin. This case report highlights gabapentin as a potential treatment for this rare headache disorder.
Area of Science:
- Neurology
- Clinical Medicine
Background:
- Short-lasting, unilateral neuralgiform headache attacks with conjunctival injection, sweating, and rhinorrhoea (SUNCT) is a rare headache disorder.
- SUNCT syndrome is characterized by severe unilateral periorbital pain accompanied by ipsilateral autonomic symptoms.
Observation:
- This case report details a patient diagnosed with SUNCT syndrome.
- The patient experienced characteristic attacks of unilateral neuralgiform headache with prominent autonomic features.
Findings:
- Successful treatment of SUNCT syndrome was achieved using gabapentin.
- Gabapentin demonstrated efficacy in managing the patient's headache attacks and associated autonomic symptoms.
Implications:
- Gabapentin represents a promising therapeutic option for managing SUNCT syndrome.
- Further research into gabapentin's role in treating SUNCT and similar headache disorders is warranted.
- Establishing clear diagnostic criteria may support the classification of SUNCT as a distinct clinical entity by the International Headache Society.